"Improving Outcomes of Infections in the Age of CFTR Modulators"

October 18, 2018

In this session, Dr. Lisa Saiman will address the challenges of infections in people with CF and discuss why infections remain a major focus of the CF community, even in the era of effective CFTR modulators. She will provide an overview of CF infections, describe ongoing studies to increase our understanding of CF microorganisms and their optimal treatment, and discuss current strategies to develop new anti-infective agents to treat even the most difficult infections.


Download Presentation Files
Lisa Saiman, M.D., M.P.H. PowerPoint PDF
Topics: Health Outcomes, Treatment, CFTR, Plenary, Clinical Research
Related: Plenary Session II: Friday, October 19, 2018